Bamco Inc. NY Boosts Position in Surgery Partners, Inc. (NASDAQ:SGRY)

Bamco Inc. NY lifted its holdings in Surgery Partners, Inc. (NASDAQ:SGRY) by 100.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 90,000 shares of the company’s stock after purchasing an additional 45,000 shares during the period. Bamco Inc. NY owned about 0.07% of Surgery Partners worth $2,685,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Wellington Management Group LLP boosted its stake in shares of Surgery Partners by 3.7% during the 4th quarter. Wellington Management Group LLP now owns 8,318,176 shares of the company’s stock worth $266,098,000 after acquiring an additional 295,476 shares during the last quarter. Vanguard Group Inc. increased its position in Surgery Partners by 0.8% in the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock worth $223,099,000 after buying an additional 61,400 shares in the last quarter. Clearbridge Investments LLC raised its stake in shares of Surgery Partners by 4.7% in the fourth quarter. Clearbridge Investments LLC now owns 5,525,671 shares of the company’s stock worth $176,766,000 after buying an additional 247,762 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Surgery Partners by 8.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,840,212 shares of the company’s stock valued at $58,870,000 after buying an additional 149,146 shares in the last quarter. Finally, Iron Triangle Partners LP bought a new position in shares of Surgery Partners during the 4th quarter valued at approximately $33,415,000.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on SGRY. Cantor Fitzgerald reissued an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a research note on Tuesday, July 9th. Citigroup dropped their target price on shares of Surgery Partners from $42.00 to $38.00 and set a “buy” rating for the company in a research report on Wednesday, May 8th. Benchmark reiterated a “buy” rating and issued a $50.00 price target on shares of Surgery Partners in a report on Wednesday, May 1st. Finally, Macquarie began coverage on Surgery Partners in a research report on Friday, June 28th. They set an “outperform” rating and a $31.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Surgery Partners currently has an average rating of “Moderate Buy” and an average target price of $40.14.

Insider Buying and Selling

In other news, insider Danielle Burkhalter sold 6,000 shares of the firm’s stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $26.39, for a total value of $158,340.00. Following the completion of the transaction, the insider now directly owns 30,354 shares in the company, valued at $801,042.06. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 2.30% of the stock is currently owned by company insiders.

Surgery Partners Trading Down 0.1 %

Shares of NASDAQ SGRY traded down $0.03 during mid-day trading on Monday, reaching $31.99. The company had a trading volume of 900,336 shares, compared to its average volume of 982,028. Surgery Partners, Inc. has a 52 week low of $22.05 and a 52 week high of $39.64. The business’s 50-day moving average is $25.78 and its 200-day moving average is $28.02. The stock has a market cap of $4.07 billion, a price-to-earnings ratio of 37.23, a price-to-earnings-growth ratio of 2.43 and a beta of 2.78. The company has a current ratio of 1.71, a quick ratio of 1.56 and a debt-to-equity ratio of 0.92.

Surgery Partners (NASDAQ:SGRY) last issued its earnings results on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.02. The company had revenue of $717.40 million for the quarter, compared to analysts’ expectations of $707.66 million. Surgery Partners had a net margin of 0.02% and a return on equity of 3.65%. Equities analysts expect that Surgery Partners, Inc. will post 0.88 earnings per share for the current year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.